Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.24.3
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity [Abstract]  
Schedule of Warrant and Stock Option Grants with Time-Based Vesting The number of shares of the Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the year ended December 31, 2023 are:
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of shares subject to warrants     Weighted-
average exercise price per share		     Number of shares subject to options     Weighted-
average exercise price per share		     Number of shares subject to restricted stock units  
Balance at December 31, 2022     104,515     $ 20.25       7,891     $ 48.75       160,653  
Granted    
-
      
-
      
-
      
-
       95,624  
Exercised     (54,872 )     9.75      
-
      
-
       (86,003 )
Cancelled/Expired     (38,249 )     23.73       (4,558 )     55.43       (4,611 )
Balance at December 31, 2023     11,394     $ 58.72       3,333     $ 39.60       165,663  
Exercisable at December 31, 2023     11,394     $ 58.72       3,333     $ 39.60       165,663  

 

The number of shares of the Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the year ended December 31, 2022 are:
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of shares subject to warrants     Weighted-
average exercise price per share		     Number of shares subject to options     Weighted-
average exercise price per share		     Number of shares subject to restricted stock units  
Balance at December 31, 2021     69,568     $ 38.55       7,891     $ 48.75       144,053  
Granted     34,947       9.75      
-
      
-
       31,021  
Exercised    
-
      
-
      
-
      
-
       (14,421 )
Cancelled/Expired    
-
      
-
      
-
      
-
      
-
  
Balance at December 31, 2022     104,515     $ 20.25       7,891     $ 48.75       160,653  
Exercisable at December 31, 2022     104,515     $ 20.25       7,891     $ 48.75       151,145  
Schedule of Company’s Outstanding Warrants and Options The Company’s outstanding warrants and options at December 31, 2023 are as follows:
Warrants Outstanding     Warrants Exercisable  
Exercise Price Range   Number Outstanding     Weighted Average Remaining Contractual Life
(in years)		     Weighted
Average Exercise Price		     Number Exercisable     Weighted Average Exercise Price     Intrinsic Value  
$51.30 – $60.00     11,394       1.62     $ 58.72       11,394     $ 58.72      
         -
  
Options Outstanding     Options Exercisable  
Exercise Price Range   Number Outstanding     Weighted Average Remaining Contractual Life
(in years)		     Weighted
Average Exercise Price		     Number Exercisable     Weighted Average Exercise Price     Intrinsic Value  
$39.60     3,333       0.91     $ 39.60       3,333     $ 39.60      
         -
  

 
Schedule of Stock-Based Compensation Expense Stock-based compensation expense for the years ended December 31, 2023 and 2022 was as follows:
    For the years ended  
    December 31,  
    2023     2022  
Stock-based compensation expense   $ 361,363     $ 1,141,932  
Schedule of Stock-Based Compensation Expense Categorized by the Equity Components Stock-based compensation expense categorized by the equity components for the years ended December 31, 2023 and 2022 is as follows:
    For the years ended  
    December 31,  
    2023     2022  
Common stock   $ 361,363     $ 1,141,932  
Total   $ 361,363     $ 1,141,932